Inovio Pharmaceuticals to Host Second Quarter 2014 Earnings Webcast Live on Monday, August 11, 2014 - FOX Carolina 21

Inovio Pharmaceuticals to Host Second Quarter 2014 Earnings Webcast Live on Monday, August 11, 2014

Posted: Updated:

PLYMOUTH MEETING, PA / ACCESSWIRE / August 8, 2014 / Inovio Pharmaceuticals, Inc. (NYSE: INO) will host a conference call and live webcast to discuss the results of the second quarter 2014, to be held Monday, August 11, 2014 at 9:00 AM Eastern Time.

You can listen to the event online at www.investorcalendar.com/IC/CEPage.asp?ID=173061 as well as via the Inovio Pharmaceuticals website (www.inovio.com).

If you are unable to participate during the live webcast, the event archive will be available at www.investorcalendar.com/ClientPage.asp?ID=173061 or www.inovio.com.

You may access a teleconference replay by dialing 877-660-6853 domestically or 201-612-7415 internationally, referencing conference ID #13588210. The replay will be available beginning approximately 2 hours after the completion of the live event, ending at midnight Eastern on September 11, 2014. 

About Inovio Pharmaceuticals, Inc.

Inovio is revolutionizing the fight against cancer and infectious diseases. Our immunotherapies uniquely activate best-in-class immune responses to prevent and treat disease, and have shown clinically significant efficacy with a favorable safety profile. With an expanding portfolio of immune therapies, the company is advancing a growing preclinical and clinical stage product pipeline. Partners and collaborators include Roche, University of Pennsylvania, NIH, HIV Vaccines Trial Network, National Cancer Institute, U.S. Military HIV Research Program, and University of Manitoba. For more information, visit www.inovio.com.

SOURCE: Inovio Pharmaceuticals, Inc.

ReleaseID: 418893

Powered by WorldNow
Fox Carolina
Powered by WorldNow CNN
All content © 2014, WHNS; Greenville, SC. (A Meredith Corporation Station) and WorldNow. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.